The acute respiratory distress syndrome (ARDS) is a life-threatening lung injury that allows fluid to leak into the lungs. It is a serious disease characterized by pulmonary dysfunction, hypoxemia and significant mortality.
This LPS-induced ARDS is suitable to screen compounds for efficacy against acute lung injury including inflammation and different pulmonary complications associated with the ARDS.
